-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
On July 23, Jiangxi Province issued the "Jiangxi Province Drug Tape Procurement Document (Draft for Comments)", published the 7 varieties of agreed procurement volume, procurement cycle, declaration eligibility and other detailed details, and publicly solicited comments.
including a total of 7 varieties including 5 PPI drugs included in this collection.
the agreed purchase volume of each variety shall be determined according to the following rules: 1 enterprise is selected, take 50% of the annual purchase volume as the agreed purchase volume, and 2 at home, take 75% of the annual purchase volume as the agreed purchase volume, of which 50% as the agreed purchase volume of the lowest-priced winning enterprise, 25% as the agreed purchase volume of the highest-ranked enterprise.
procurement cycle: 1 in the selection of enterprises, the procurement period is 1 year, and 2 selected in 2 enterprises, the procurement cycle is 2 years.
purchase and sale agreement signed every year during the purchase cycle.
if the purchase period in advance of the completion of the current year's agreed purchase volume, more than part of the selected enterprises still in accordance with the selected price in a timely and sufficient amount of supply, until the purchase cycle expires.
When the results of centralized procurement of national drugs in the procurement cycle and the results of the central drug procurement in our province cross, such as the winning enterprises are different, the results of the national drug centralized procurement are implemented;
bid requirements: The enterprise bid variety and the auction group contain at least 1 main product regulation.
enterprise bid varieties in 2019 production reached 2 times the quantity of this purchase (including) or more.
the procurement cycle, medical institutions will give priority to the use of drug belt procurement of selected drugs, and ensure the completion of the agreed purchase volume.
the remaining amount of other drugs at the appropriate price of the same variety can be purchased according to demand.
the winning price is not disclosed through the official website within a certain time frame.
in the process of implementation, if the selected products and the national concentrated volume procurement varieties, the implementation of the link with the relevant national policies.
the following original text:source:Source:Supplied